Aquestive Therapeutics, Inc. (AQST) Net income 2017–2025
Aquestive Therapeutics, Inc. (AQST) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$83.8MFY2025 · since FY2017: -$8.9M → -$83.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$83.8M | -89.8% |
| FY2024 | -$44.1M | -460.8% |
| FY2023 | -$7.9M | +85.5% |
| FY2022 | -$54.4M | +22.9% |
| FY2021 | -$70.5M | -26.5% |
| FY2020 | -$55.8M | +15.8% |
| FY2019 | -$66.2M | -7.9% |
| FY2018 | -$61.4M | -586.3% |
| FY2017 | -$8.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice